DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
WNW Announces Strategic AI Insights Initiative to Support Functional Skincare Product Innovation
Kyodo News PR Wire (March 16, 2026, distributed via PR Newswire) reported that Meiwu Technology Company Limited (NASDAQ: WNW), a Shenzhen-based company, announced an AI insights initiative to enhance research collaboration and operational efficiency across its functional skincare business. Initiative details: Plans to explore application of AI-assisted data analysis tools for internal research coordination, product formulation analysis, and collaboration with external research partners. Key expected benefits: (1) improved efficiency in organizing and evaluating growing research data (formulation records, ingredient studies, skincare technology academic publications); (2) identification of potential ingredient interactions; (3) facilitation of more standardized data sharing among research participants. CEO Zhichao Yang commented: 'AI-assisted analytical tools are increasingly being used across research-driven industries to help teams manage complex datasets and streamline internal workflows. By exploring these technologies within our research processes, we aim to enhance coordination between internal teams and external research partners, while supporting more efficient evaluation of formulation data and ingredient research.' The company has already completed a strategic transition from online food sales and SMS businesses to the skincare industry, selling functional skincare products through its subsidiary in China.
Fully Synthetic Metabolic Pathway 'ReForm' Converts CO2-Derived Formate to Acetyl-CoA Non-Natural Engineered Enzymes Successfully Synthesize Malate for Food, Cosmetics, and Biodegradable Plastics
Stanford University News (January 2026) reported on research published in Nature Chemical Engineering (DOI: 10.1038/s44286-025-00315-6) by synthetic biologists at Stanford University and Northwestern University. The team overcame the fundamental challenge that no enzyme system exists in nature to directly convert CO2 to acetyl-CoA (the universal metabolite used by all living cells), developing the 'ReForm (Reductive Formate Pathway)' system. Starting from formate—a simple liquid easily made from CO2 using electricity and water—the team screened 66 enzymes and over 3,000 enzyme variants to build the ReForm pathway. Operating in a cell-free synthetic biology system (without cell walls), it eliminates constraints inherent to living microbes (product toxicity, precise growth conditions, unpredictable evolution), enabling precise tuning of each chemical step. As a proof of concept, the same system converted acetyl-CoA into malate—a commercially valuable chemical used in foods, cosmetics, and biodegradable plastics with a $600M global market. The pathway works with multiple one-carbon feedstocks (formate, formaldehyde, methanol) and is expected to enable carbon-negative manufacturing by combining electrochemistry and synthetic biology.
UK NHS Launches World's Largest Clinical Trial of Non-Invasive Vagus Nerve Stimulation for At-Home Stroke Rehabilitation: The £2M Triceps Project Across 19 NHS Facilities
UNN (Ukrainian News Agency, February 15, 2026), citing BBC reporting, reported that the UK has launched a large-scale clinical trial of an innovative device for at-home stroke rehabilitation. The £2 million Triceps project involves 19 NHS medical facilities and has become the world's largest study of the effect of brain stimulation on stroke recovery. The technology uses a compact electrical device placed in the auricle (ear) to deliver non-invasive vagus nerve stimulation (VNS)—unlike previous VNS approaches that required surgical electrode implantation, this device is completely non-invasive and designed for safe self-use at home. During daily rehabilitation exercises, the device sends weak electrical impulses to the brain, making it more receptive to restoring lost neural connections by harnessing neuroplasticity. Dr. Sheharyar Baig, a neurologist from Sheffield, notes that stroke is the leading cause of adult disability in the UK, affecting around 100,000 people each year, and that home-based technology allows patients to exercise more intensively and for longer—critical for regaining the ability to perform basic household tasks. Preliminary data from 200+ participants show highly promising early signs: clinicians are recording significant improvement in fine motor skills, with patients who previously could not hold a cup now confidently carrying it between rooms. Researchers are also conducting blood tests and brain imaging to understand why some patients respond better to the technology. If successful, the device could be integrated into standard rehabilitation systems at scale.
Brain-Computer Interface High-Volume Production and Fully Automated Surgery to Launch in 2026—New Transdural Approach Announced
Reuters (January 1, 2026) reported that the founder of a brain implant company stated in a social media post on platform X that the company will start 'high-volume production' of brain-computer interface (BCI) devices and move to an almost entirely automated surgical procedure in 2026. The post also mentioned a new approach where device threads will go through the dura (the membrane protecting the brain) without the need to remove it, describing this as 'a big deal.' The company began human trials of its brain implant in 2024 after addressing safety concerns raised by the FDA. As of September 2024, 12 people worldwide with severe paralysis had received brain implants and were using them to control digital and physical tools through thought alone. The first patient has used the device to play video games, browse the internet, post on social media, and move a cursor on a laptop. The company closed a $650 million funding round in June 2024. Regulators and researchers continue to monitor safety, scalability, and long-term outcomes in the neurotechnology field.
12-Week Supplementation with Silkworm Cordyceps Militaris Significantly Improves Male Menopausal Symptoms in Men 40+ in Randomized Double-Blind Placebo-Controlled Trial: Significant Improvements in Total AMS Score, Psychological and Physical Subscales (Published in Japanese Anti-Aging Medicine Journal)
Dai-ichi Kogyo Seiyaku Co., Ltd. (Kyoto) announced on March 16, 2026, that a clinical trial has confirmed supplementation with the food ingredient silkworm Cordyceps militaris (Silkworm Cordyceps) improves male menopausal symptoms in men aged 40 and over. The results were published in the February 2026 issue of 'Anti-Aging Medicine,' the journal of the Japan Society of Anti-Aging Medicine. Male menopausal symptoms—including depression, sleep disorders, sexual dysfunction, irritability, and hot flashes—significantly affect men's quality of life and have been associated with metabolic syndrome, cardiovascular disease, and dementia risk. The company had previously demonstrated that Silkworm Cordyceps improves sleep quality and increases testosterone levels in obese men. The current study was a randomized, placebo-controlled, double-blind parallel-group comparative trial in 68 men aged 40 and over (65 analyzed), comparing 12 weeks of Silkworm Cordyceps versus placebo supplementation. Outcome measures were the Aging Male Symptoms (AMS) questionnaire total score and three subscales: psychological, somatic, and sexual function factors. The results showed statistically significant improvement in the total AMS score as well as the psychological and somatic subscales. The company states it will continue to advance research on Silkworm Cordyceps to address the challenges of stress-laden and rapidly aging societies.
This new building material pulls carbon out of the air
Researchers at Worcester Polytechnic Institute have developed a new building material, "Enzymatic Structural Material (ESM)," that utilizes an enzyme to convert CO2 into solid minerals. This material cures in hours, significantly reduces energy consumption compared to traditional concrete production, and actively captures carbon instead of releasing it. ESM is strong, durable, and recyclable, expected to make a substantial contribution to reducing emissions in the construction industry and fostering sustainable infrastructure.
Thirteen companies join L’Oréal’s sustainable innovation accelerator
L’Oréal has announced the first 13 companies selected for its sustainable innovation program, "L’AcceleratOR." These companies specialize in packaging, natural ingredients, and circular solutions, chosen from 1,000 applications across 101 countries. Partnering with the University of Cambridge Institute for Sustainability Leadership and backed by a EUR 100 million budget over five years, the program aims for selected companies to undertake 6-9 month pilot projects and leverage L’Oréal's global resources to scale sustainable solutions.
Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable
Jurek Kozyra, CEO of Nanovery, is revolutionizing molecular medicine with DNA nanorobots that could cure previously incurable diseases. These self-assembling machines, combining DNA nanotechnology and AI, dramatically reduce diagnostic times from days to hours and accelerate drug development, potentially shortening the decade-long journey for life-saving treatments. DNA nanorobots can detect diseases in blood samples within 2-4 hours, demonstrating equivalent or better accuracy than traditional tests in clinical settings, marking a significant breakthrough for rapid diagnostics in emergency situations.
New Frontiers in Biomedicine: Creative Biolabs Advances Eukaryotic Microorganism Exosome R&D
Creative Biolabs is expanding its exosome R&D to include eukaryotic microorganisms like fungi and protozoa. This initiative aims to utilize fungus-derived exosomes for immunomodulation and antifungal vaccines, and protozoon-derived exosomes to unravel parasite immune evasion mechanisms, develop blocking therapies for tropical diseases, and create early diagnostic biomarkers. The company has launched a service platform for high-purity isolation and characterization, intending to leverage these exosomes as carriers for innovative cell-free vaccines and intelligent drug delivery systems.
Dutch Tech Aids Muscle Study in Lunar Gravity
Researchers from FH Aachen University utilized the 'ProbeFix Dynamic T' device from Dutch medical technology company Usono during the 88th ESA Parabolic Flight Campaign to precisely measure muscle movements under simulated lunar gravity conditions. This device securely attaches an ultrasound probe to the muscle, ensuring image stability despite movement and gravity changes, enabling accurate data acquisition. This technology is expected to contribute not only to space research but also to accelerating rehabilitation in sports medicine and physiotherapy.
Scientists Identify Brain Waves That Define The Limits of 'You'
The tests, which in one experiment involved EEG (electroencephalography) readings of brain activity, revealed that a sense of body ownership seems to arise from the frequency of alpha waves in the parietal cortex, a brain region responsible for mapping the body, processing sensory input and building a sense of self.
"We have identified a fundamental brain process that shapes our continuous experience of being embodied," says lead author Mariano D'Angelo, a neuroscientist at Karolinska Institute in Sweden.
"The findings may provide new insights into psychiatric conditions such as schizophrenia, where the sense of self is disturbed."
Exercise 'Snacks' Throughout Your Day Have Real Health Benefits, Study Finds
Your fitness tracker might be telling you that you need 10,000 steps, 30 minutes of cardio or even an hour at the gym every day. But what if you could improve your health in just a few minutes a day? A growing body of research suggests you can.
"Exercise snacks" are brief bursts of vigorous exercise, typically lasting one minute or less, scattered throughout your day. Think climbing a few flights of stairs, doing some squats during a work break, or a quick burst of jumping jacks before lunch.
Unlike traditional workouts, these "snacks" aren't done back-to-back – they're spread across your waking hours, separated by one to four hours of your regular activities such as working, commuting, or watching TV.
SetPoint Medical Receives FDA Approval for Novel Neuroimmune Modulation Therapy for Rheumatoid Arthritis
SetPoint Medical announced FDA approval for its SetPoint System, the first neuroimmune modulation device for moderate-to-severe rheumatoid arthritis (RA) patients unresponsive to existing therapies. This implantable device delivers vagus nerve stimulation to activate anti-inflammatory pathways, offering a treatment option without immune-compromising risks. Supported by the RESET-RA study, which showed significant efficacy and safety, SetPoint plans a targeted U.S. launch this year, with broader expansion in early 2026, and intends to explore its platform for other autoimmune conditions like multiple sclerosis and Crohn’s disease.